Preview Mode Links will not work in preview mode

Mar 26, 2021

Featuring perspectives from Dr Michael J Birrer on the following topics:

  • Anti-PD-1/PD-L1 Checkpoint Inhibitors for Gynecologic Cancers (0:00)
  • HER2-Positive Endometrial Cancer (43:24)
  • Tisotumab Vedotin and Other Novel Agents in Gynecologic Cancers (47:57)

CME information and select publications